Matters of legal in nature including licensing, intellectual property, and lawsuits.
OMAHA, Neb. (June 13, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that the European Patent Office (EPO) has confirmed its intention to grant a patent covering multiplexed ICE COLD-PCR (MX-ICP) technology in the European Union (EU). This Dana-Farber Cancer Institute patent is exclusively licensed to Transgenomic. Paul Kinnon, President and CEO of Transgenomic, commented,... Read more
MILWAUKEE – June 9, 2017 – Demand for quality used parts has increased as hospitals and healthcare systems have become more sophisticated about medical equipment maintenance and management. Now more than 10,000 types of refurbished parts for GE Diagnostic Imaging equipment are available as GoldSeal parts from GE Healthcare. Hospital in-house service departments can find... Read more
New LC/MS Triple Quadrupole is 70% Smaller Footprint but Equivalent Performance to Larger Instruments SANTA CLARA, Calif., June 5, 2017 Agilent Technologies Inc. (NYSE: A) today, introduced the newest member of its family of triple quadrupole liquid chromatography mass spectrometers (triple quad LC/MS) at the American Society for Mass Spectrometry Conference (ASMS), being held June... Read more
Analytical laboratories can now obtain high quality data with new triple quadrupole mass spectrometry technology designed to provide exceptional performance for the most demanding targeted quantitation applications in the environmental, food safety, pharmaceutical and biopharmaceutical industries as well as clinical research and forensic toxicology. The new Thermo Scientific TSQ Altis Triple Stage Quadrupole mass spectrometer... Read more
Kyoto, Japan and Québec, Canada – June 5, 2017. Shimadzu, one of the world’s fastest growing mass spectrometry companies, and Phytronix, world leader in high throughput analysis in mass spectrometry, announce today that they have signed an agreement to offer the industry’s first Triple Ion Source. Ideal for both screening and confirmation work, this new... Read more
Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, June 3, 2017 – QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide license from The Johns Hopkins University for biomarkers that have been shown to play... Read more
San Carlos, California , May 30, 2017 NuGEN Technologies today announced that the United States Patent and Trademark Office has issued US Patent No. US 9,650,628 describing the Single Primer Target Enrichment Technology (SPET) which enables targeted nucleic acid analysis by next generation sequencing (NGS). NuGEN offers commercial solutions using SPET to create target and strand-specific libraries... Read more
Presentation Slides on Mar. 29, 2017, and Q&A session Transcript (Summary) Read more
Basel, 24 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in patients with more advanced lung function impairment and the risk of respiratory-related hospitalisations as a first... Read more
Basel, 24 May 2017 New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF) In new post hoc analyses of phase III data, Esbriet reduced the risk of death in patients with more advanced lung function impairment and the risk of respiratory-related hospitalisations as a first... Read more